Pages that link to "Property:P307"
Jump to navigation
Jump to search
The following pages link to published in (P307):
Displayed 50 items.
- The impact of COVID-19 restrictions on HIV prevention and treatment services for key populations in South Africa: an interrupted time series analysis (Q29482) (← links)
- Consequences of bathroom restriction on transgender individuals with gastrointestinal conditions in the United States (Q29491) (← links)
- Safe and supportive prescribing in transgender and non-binary patients with cancer (Q29504) (← links)
- Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals (Q29540) (← links)
- Realist evaluation of a community-based antiretroviral therapy (CBART) programme for key populations in Benue State in Nigeria (Q29557) (← links)
- Case 1: Clitoromegaly, Oligomenorrhea, and Hirsutism in a 17-year-old Transgender Male (Q29565) (← links)
- Clinical Characteristics and Care Trajectories of Transgender and Gender Diverse Patients With Cancer Seen in a Pediatric Gender Clinic (Q29585) (← links)
- The association of depression with all-cause and cardiovascular disease mortality risk among transgender and gender diverse and cisgender patients (Q29591) (← links)
- Androgen Inhibition of Reproductive Neuroendocrine Function in Females and Transgender Males (Q29604) (← links)
- Institutional Violence Perpetrated against Transgender Individuals in Health Services: A Systematic Review of Qualitative Studies (Q29611) (← links)
- Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs (Q29626) (← links)
- Aesthetic Considerations for Neuromodulator Use in Transgender Patients (Q29638) (← links)
- Depression and anxiety in transgender and non-binary adolescents: prevalence and associations between adolescent and caregiver reports (Q29659) (← links)
- Enhanced Cohort Methods for HIV Research and Epidemiology (ENCORE): Protocol for a Nationwide Hybrid Cohort for Transgender Women in the United States (Q29699) (← links)
- Reproductive Health in Trans and Gender Diverse Patients: Effects of transmasculine gender-affirming hormone therapy on future reproductive capacity: clinical data, animal models, and gaps in knowledge (Q29717) (← links)
- Understanding Gaps of HIV Knowledge Among Transgender Young Adults: A Pilot Interview Study (Q29724) (← links)
- Missed Opportunity or Cause for Concern? Methamphetamine Use Is Associated With Greater Interest in Event-Driven PrEP Among Sexual Minority Men (Q29743) (← links)
- Perceived Feasibility and Acceptability of HIV Prevention Research With Daily Oral PrEP Among Young Transgender Women (YTGW) Who Sell or Trade Sex in Bangkok and Pattaya, Thailand (Q29762) (← links)
- Venous thromboembolism in transgender and gender non-binary youth is rare and occurs in the setting of secondary risk factors: A retrospective cohort study (Q29775) (← links)
- Health care needs and barriers to care among the transgender population: a study from western Rajasthan (Q29794) (← links)
- Clinical pharmacology in adolescent transgender medicine (Q29809) (← links)
- A Microfinance Intervention With or Without Peer Support to Improve Mental Health Among Transgender and Nonbinary Adults (the Creating Access to Resources and Economic Support Study): Protocol for a Randomized Controlled Trial (Q29821) (← links)
- Transgender Adolescent School Climate, Mental Health, and Adult Social Support (Q29828) (← links)
- Validation of Lower Urinary Tract Symptom Questionnaire in the Transmasculine Population (Q29844) (← links)
- Cass Report and Implications for Transgender Youth and Services in ROI (Q29852) (← links)
- Medical student clinical cultural awareness in cancer care of sexual gender minority patients (Q29872) (← links)
- Embracing the Need to Learn About the Health Needs of Transgender People (Q29876) (← links)
- Bridging the Gaps and Improving Care: Comprehensive Medication Management for Transgender Patients (Q29881) (← links)
- Transgender patients and gender-affirming hormone therapy through the mid-life (Q29890) (← links)
- Emotion regulation strategies and coping self-efficacy as moderators of daily associations between transgender and gender diverse (TGD) enacted stigma and affect among TGD young adults assigned female at birth (Q29898) (← links)
- Using AI and Social Media to Understand Health Disparities for Transgender Cancer Care (Q29910) (← links)
- Transgender health research needed (Q29916) (← links)
- Antitrans Policy Environment and Depression and Anxiety Symptoms in Transgender and Nonbinary Adults (Q29936) (← links)
- The "Cycle" of HIV: Limits of Personal Responsibility in HIV Vulnerability Among Transgender Adolescents and Young Women in Lima, Peru (Q29957) (← links)
- Transgender lives at the population level: Evidence from Danish administrative data (Q29963) (← links)
- ASO Author Reflections: Collaborative Surgical Care in the Transgender Community (Q29970) (← links)
- The Role of Sex and Gender in Transgender Bone and Other Musculoskeletal Health (Q29977) (← links)
- "They treat us as equals, they guide us": peer navigation for HIV care engagement with men who have sex with men and transgender women in Lima, Peru (Q29985) (← links)
- Profile and experiences during the incarceration of transgender women and travestis (TGW) in Brazil: a cross-sectional study (Q30001) (← links)
- Lifetime sexual violence among transgender women and travestis (TGW) in Brazil: Prevalence and associated factors (Q30006) (← links)
- Discrimination based on gender identity against transgender women and travestis in Brazil: a latent class analysis and associated factors (Q30011) (← links)
- Multiple substance use and associated factors in transgender women and travestis: findings from the TransOdara Study, Brazil (Q30015) (← links)
- Bodies of desire: use of nonprescribed hormones among transgender women and travestis in five Brazilian capitals (2019–2021) (Q30022) (← links)
- Physical examination for the detection of sexually transmitted infections among transgender women and travestis in Brazil: acceptability and associated factors (Q30030) (← links)
- Factors associated with prior testing for HIV, Syphilis, and Hepatitis B and C among transgender women and travestis in Brazil (Q30031) (← links)
- Difficulties and advances in access to and use of health services by transgender women and travestis in Brazil (Q30035) (← links)
- Prevalence of chlamydia and gonorreheae among transgender women and travestis in five Brazilian capitals, 2019–2021 (Q30044) (← links)
- Hepatitis A, B and C prevalence among transgender women and travestis in five Brazilian capitals between 2019-2021 (Q30060) (← links)
- Prevalence of HIV infection among transgender women and travestis in Brazil: data from the TransOdara study (Q30061) (← links)
- Prevalence of syphilis in transgender women and travestis in Brazil: results from a national cross-sectional study (Q30068) (← links)